Efficacy of Chronic Morphine in a Rat Model of Cancer-Induced Bone Pain: Behavior and in Dorsal Horn Pathophysiology

Cherny, 2000, The management of cancer pain, CA Cancer J Clin, 50, 70, 10.3322/canjclin.50.2.70 Donovan-Rodriguez, 2004, Superficial dorsal horn neuronal responses and the emergence of behavioural hyperalgesia in a rat model of cancer-induced bone pain, Neurosci Lett, 360, 29, 10.1016/j.neulet.2004.01.048 Donovan-Rodriguez, 2005, Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain, Anesthesiology, 102, 132, 10.1097/00000542-200501000-00022 Honore, 2000, Neurochemical plasticity in persistent inflammatory pain, Prog Brain Res, 129, 357, 10.1016/S0079-6123(00)29027-4 Luger, 2002, Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain, Pain, 99, 397, 10.1016/S0304-3959(02)00102-1 Matthews, 2002, A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy, Anesthesiology, 96, 633, 10.1097/00000542-200203000-00020 Medhurst, 2002, A rat model of bone cancer pain, Pain, 96, 129, 10.1016/S0304-3959(01)00437-7 Menendez, 2003, Peripheral opioids act as analgesics in bone cancer pain in mice, Neuroreport, 14, 867, 10.1097/00001756-200305060-00018 Menendez, 2003, Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain, Brain Res, 969, 102, 10.1016/S0006-8993(03)02284-4 Mercadante, 1997, Malignant bone pain, Pain, 69, 1, 10.1016/S0304-3959(96)03267-8 Mercadante, 1998, Breakthrough pain in cancer patients, Cancer Treat Rev, 24, 425, 10.1016/S0305-7372(98)90005-6 Mercadante, 2004, Optimization of opioid therapy for preventing incident pain associated with bone metastases, J Pain Symptom Manage, 28, 505, 10.1016/j.jpainsymman.2004.02.024 Portenoy, 1999, Pain management, Cancer Treat Res, 29, 1001 Portenoy, 1999, Breakthrough pain, Pain, 81, 129, 10.1016/S0304-3959(99)00006-8 Portenoy, 1999, Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients, Pain, 79, 303, 10.1016/S0304-3959(98)00179-1 Rhiner, 2004, Managing breakthrough pain, Clin J Oncol Nurs, 8, 507, 10.1188/04.CJON.507-512 Rygh, 2000, Effect of spinal morphine after long-term potentiation of wide dynamic range neurones in the rat, Anesthesiology, 92, 140, 10.1097/00000542-200001000-00025 Sabino, 2003, Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system, Int J Cancer, 104, 550, 10.1002/ijc.10999 Schwei, 1999, Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain, J Neurosci, 19, 10886, 10.1523/JNEUROSCI.19-24-10886.1999 Stanfa, 1995, Spinal opioid systems in inflammation, Inflamm Res, 44, 231, 10.1007/BF01782974 Suzuki, 1999, The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain, Pain, 80, 215, 10.1016/S0304-3959(98)00208-5 Urch, 2004, The pathophysiology of cancer-induced bone pain, Palliat Med, 18, 267, 10.1191/0269216304pm887ra Urch, 2003, In vivo single unit extracellular recordings from spinal cord neurones of rats, Brain Res Brain Res Protoc, 12, 26, 10.1016/S1385-299X(03)00068-0 Urch, 2003, Alterations in dorsal horn neurones in a rat model of cancer induced bone pain, Pain, 106, 347, 10.1016/j.pain.2003.08.002 Vermeirsch, 2004, Bone cancer pain model in mice, Pharmacol Biochem Behav, 79, 243, 10.1016/j.pbb.2004.07.011